Cytokeratin-Positive Meningeal Peripheral PNET/Ewing's Sarcoma of the Cervical Spinal Cord: Diagnostic Value of Genetic Analysis

Abstract

Peripheral primitive neuroectodermal tumor (PNET)/Ewing's sarcoma (ES) of the central nervous system is extremely rare and should be differentiated from central PNET and other small blue round cell tumors. We describe a case of a meningeal peripheral PNET/ES of the spinal cord in an 11 -year-old boy. Immunohistochemically, the small blue round cell tumor showed expression of epithelial markers and of CD99, thus posing an important differential diagnostic problem with a poorly differentiated synovial sarcoma. Fluorescence in situ hybridization revealed rearrangement of the EWS gene, as seen in peripheral PNET/ES. Peripheral PNET/ES does occur in the central nervous system, but its diagnosis can be extremely difficult on morphologic and immunohistochemical grounds alone. Genetic analysis plays a key role in its distinction from other small blue round cell tumors.

Keywords

primitive neuroectodermal tumor Ewing's sarcoma synovial sarcoma cytokeratin t(1 1;22)meninges spinal cord

Get full access to this article

View all access options for this article.

References

1. Paulussen M , Frohlich B , Jurgens H . Ewing tumor: Incidence, prognosis and treatment options. Paediatr Drugs 3:899-913, 2001

2. Dei Tos AP , Wadden C , Calonje E , et al. Immunohistochemical demonstration of glycoprotein p30/32MIC2 (CD99) in synovial sarcoma: A potential cause of diagnostic confusion. Appl Immunohistochem 3:168-173, 1995

3. Arvand A , Denny CT . Biology of EWS/ETS fusions in Ewings's family tumors. Oncogene 20:5747-5754, 2001

4. Dedeurwaerdere F , Giannini C , Sciot R , Rubin BP , Perilongo G , Borghi L , et al. Primary peripheral PNET/Ewing's sarcoma of the dura: A clinicopathological entity distinct from central PNET. Mod Pathol 15:673-678, 2002

5. Machen K , Fisher C , Gautam, Tubbs , Goldblum JR . Utility of cytokeratin subsets for distinguishing poorly differentiated synovial sarcoma from peripheral primitive neuroectodermal tumor. Histopathology 33:501-507, 1998

6. Mai G , Antonescu CR , Guiter G , Huvos AG , Ladanyi M , Zakowski MF . Cytokeratin immunoreactivity in Ewing's sarcoma. Am J Surg Pathol 24:410-416, 2000

7. Nielsen TO , Hsu FD , O'Connell JX , Gilks CB , Sorensen PHB , Linn S , West RB , Liu CL , Botstein D , Brown PO , van de Rijn M . Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology. Am J Pathol 163:1449-1456, 2003

8. de Alava E , Kawai A , Healey JH , Fligman I , Meyers PA , Huvos AG , et al. EWS-FLII fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol 16:1248-1255, 1998

9. de Alava E , Panizo A , Antonescu CR , Huvos AG , Pardo-Mindan FJ , Barr FG , et al. Association of EWS-FLI1 type-I fusion with lower proliferative rate in Ewing's sarcoma. Am J Pathol 156:849-855, 2000